The ACCJ Journal
Rob Claar, CEO and founder of healthcare investment, development, and commercialization platform HekaBio joins us to discuss how overseas healthcare companies can gain regulatory approval in Japan and put their innovations in the hands of Japanese doctors and patients.
18 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The ACCJ Journal-Community!